EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decoding Osteosarcoma’s Lactylation Gene Expression: Insights Into Prognosis, Immune Dynamics, and Treatment

Cheng Peng iD, Chaoqun You iD, Shuang Cao iD, Linfei Cheng iD, Jiaji Ren iD, Jiashi Cao iD, Jing Wang iD, Tielong Liu iD

Analytical Cellular Pathology · 2025-01 · 2025 (1)

DOI: 10.1155/ancp/6517238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Cellular Pathology, online erschienen am 21.02.2025. Verfasst von Cheng Peng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Changzheng Hospital, Naval Medical University, Shanghai 200003, China. Hauptthemen laut MEDLINE: Osteosarcoma, Gene Expression Regulation, Neoplastic, Bone Neoplasms, Protein Processing, Post-Translational. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS), characterized by a complex tumor microenvironment, poses challenges in treatment, metastasis, and therapy resistance. This study examined the impact of lactylation, a posttranslational modification, on gene expression and tumor behavior in OS, particularly its influence on prognosis, immune cell infiltration, and chemotherapy response. Utilizing data from the Gene Expression Omnibus series accession number 21257 (GSE21257) and the Therapeutically Applicable Research to Generate Effective Treatments on Osteosarcoma (TARGET‐OS) datasets, the investigation focused on analyzing the expression profiles of 267 lactylation modifier genes, which were selected from a total of 336 lactylation‐related genes compiled from various studies in the literature. The methods included unsupervised clustering using “ConsensusClusterPlus” heatmap generation with “pheatmap” pathway analysis from several databases, and immune cell infiltration assessment using the “single‐sample Gene Set Enrichment Analysis (ssGSEA)” function. The research revealed 36 significant lactylation‐related genes in OS, categorizing them into two clusters with distinct survival and biological characteristics. One cluster demonstrated poor prognosis due to increased tumor cell proliferation and specific immune cell variations, also showcasing genes that enhance tumor growth and metastasis, thus indicating its aggressive nature and adverse outcomes for patients. These insights are crucial for understanding the molecular mechanisms of OS and identifying therapeutic targets. Therefore, the study elucidates the role of lactylation‐related genes in the prognosis, pathogenesis, and treatment response of OS, laying the groundwork for further exploration into potential therapeutic targets and the underlying mechanisms within OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaGene Expression Regulation, NeoplasticBone NeoplasmsProtein Processing, Post-TranslationalHumansPrognosisGene Expression ProfilingTumor MicroenvironmentCluster Analysis

Stichwörter der Autor:innen

gene expressionimmune system phenomenaosteosarcomaprognosistumor microenvironment

Autor:innen und Institutionen

  • Department of Orthopedics, Changzheng Hospital, Naval Medical University, Shanghai 200003, China.
  • Department of Orthopedics, Clinical Medical College, Weifang Medical University, Weifang 261053, Shandong, China.
  • Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200021, China.
  • School of Medicine, Anhui University of Science and Technology, Huainan 232001, China.
  • Department of Orthopedics, No. 455 Hospital of the Chinese People's Liberation Army, The Navy Medical University, Shanghai 200052, China.

ORCID-Profile: Cheng Peng, Chaoqun You, Shuang Cao, Linfei Cheng, Jiaji Ren, Jiashi Cao, Jing Wang, Tielong Liu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Peng, C., You, C., Cao, S., Cheng, L., Ren, J., Cao, J., Wang, J., & Liu, T. (2025). Decoding Osteosarcoma’s Lactylation Gene Expression: Insights Into Prognosis, Immune Dynamics, and Treatment. Analytical Cellular Pathology, 2025(1). https://doi.org/10.1155/ancp/6517238

Vancouver

Peng C, You C, Cao S, Cheng L, Ren J, Cao J, et al. Decoding Osteosarcoma’s Lactylation Gene Expression: Insights Into Prognosis, Immune Dynamics, and Treatment. Analytical Cellular Pathology. 2025;2025(1). doi:10.1155/ancp/6517238

BibTeX
@article{Peng2025,
  author = {Peng, Cheng and You, Chaoqun and Cao, Shuang and Cheng, Linfei and Ren, Jiaji and Cao, Jiashi and Wang, Jing and Liu, Tielong},
  title = {Decoding Osteosarcoma’s Lactylation Gene Expression: Insights Into Prognosis, Immune Dynamics, and Treatment},
  journal = {Analytical Cellular Pathology},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/ancp/6517238}
}
Kostenlos starten →